| [1] | Alaedini A, Green PH (2005) Narrative review: celiac disease: understanding a complex autoimmune disorder. Annals of Internal Medicine 142: 289–298.
|
| [2] | Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, et al. (2011) Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord13: 52–58.
|
| [3] | Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, et al. (2010) Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 68: 100–104.
|
| [4] | Dohan FC (1979) Schizophrenia and neuroactive peptides from food. Lancet 1: 1031.
|
| [5] | Dohan FC (1970) Coeliac disease and schizophrenia. Lancet 1: 897–898.
|
| [6] | Dohan FC (1980) Hypothesis: genes and neuroactive peptides from food as cause of schizophrenia. Adv Biochem Psychopharmacol 22: 535–548.
|
| [7] | Dohan FC (1981) Schizophrenia, celiac disease, gluten antibodies, and the importance of beta. Biol Psychiatry 16: 1115–1117.
|
| [8] | Reichelt KL, Seim AR, Reichelt WH (1996) Could schizophrenia be reasonably explained by Dohan’s hypothesis on genetic interaction with a dietary peptide overload? Progress in Neuro-Psychopharmacology & Biological Psychiatry 20: 1083–1114.
|
| [9] | Whiteley P, Haracopos D, Knivsberg AM, Reichelt KL, Parlar S, et al. (2010) The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci 13: 87–100.
|
| [10] | Reichelt KL (1994) Exorphins in Schizophrenia and Autism. Journal of Neurochemistry 63: S86–S86.
|
| [11] | Severance EG, Alaedini A, Yang S, Halling M, Gressitt KL, et al. (2012) Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res 138: 48–53.
|
| [12] | Severance EG, Dickerson FB, Halling M, Krivogorsky B, Haile L, et al. (2010) Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia. Schizophr Res 118: 240–247.
|
| [13] | Severance EG, Dupont D, Dickerson FB, Stallings CR, Origoni AE, et al. (2010) Immune activation by casein dietary antigens in bipolar disorder. Bipolar Disord 12: 834–842.
|
| [14] | Samaroo D, Dickerson F, Kasarda DD, Green PH, Briani C, et al. (2010) Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 118: 248–255.
|
| [15] | Dohan FC (1988) Genetic hypothesis of idiopathic schizophrenia: its exorphin connection. Schizophr Bull 14: 489–494.
|
| [16] | Reichelt KL (1991) Peptides in Schizophrenia. Biol Psychiatry 29: 515–516.
|
| [17] | Reichelt KL, Reichelt WH, Stensrud M (1995) The role of peptides in schizophrenia. Journal of Neurochemistry 65: S43–S43.
|
| [18] | Reichelt KL, Stensrud M (1998) Increase in urinary peptides prior to the diagnosis of schizophrenia. Schizophr Res 34: 211–213.
|
| [19] | Flegr J, Lenochova P, Hodny Z, Vondrova M (2011) Fatal attraction phenomenon in humans: cat odour attractiveness increased for toxoplasma-infected men while decreased for infected women. PLoS Neglected Tropical Diseases 5: e1389.
|
| [20] | Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H (2012) Behavioral changes in mice caused by Toxoplasma gondii invasion of brain. Parasitology Research 111: 53–8.
|
| [21] | Goodwin DG, Hrubec TC, Klein BG, Strobl JS, Werre SR, et al. (2012) Congenital infection of mice with Toxoplasma gondii induces minimal change in behavior and no change in neurotransmitter concentrations. The Journal of Parasitology 98: 706–12.
|
| [22] | Kannan G, Moldovan K, Xiao JC, Yolken RH, Jones-Brando L, et al. (2010) Toxoplasma gondii strain-dependent effects on mouse behaviour. Folia parasitologica 57: 151–155.
|
| [23] | Torrey EF, Bartko JJ, Yolken RH (2012) Toxoplasma gondii and other risk factors for schizophrenia: An update. Schizophr Bull 38: 642–7.
|
| [24] | Torrey EF, Bartko JJ, Lun ZR, Yolken RH (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33: 729–736.
|
| [25] | Webster JP, McConkey GA (2010) Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia parasitologica 57: 95–104.
|
| [26] | Webster JP (2007) The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull 33: 752–756.
|
| [27] | Webster JP (2001) Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes and infection/Institut Pasteur 3: 1037–1045.
|
| [28] | Xiao J, Kannan G, Jones-Brando L, Brannock C, Krasnova IN, et al. (2012) Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience 206: 39–48.
|
| [29] | Bereswill S, Munoz M, Fischer A, Plickert R, Haag LM, et al. (2010) Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5: e15099.
|
| [30] | Erridge C, Duncan SH, Bereswill S, Heimesaat MM (2010) The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PloS One 5: e9125.
|
| [31] | Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, et al. (2009) Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 206: 3047–3059.
|
| [32] | Schreiner M, Liesenfeld O (2009) Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL/6 mice: review of 70 reports from the literature. Mem Inst Oswaldo Cruz 104: 221–233.
|
| [33] | Craven M, Egan CE, Dowd SE, McDonough SP, Dogan B, et al. (2012) Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn’s disease. PloS One 7: e41594.
|
| [34] | Hand TW, Dos Santos LM, Bouladoux N, Molloy MJ, Pagan AJ, et al. (2012) Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 337: 1553–1556.
|
| [35] | Lidar M, Lipschitz N, Langevitz P, Barzilai O, Ram M, et al. (2009) Infectious serologies and autoantibodies in Wegener’s granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Annals of the New York Academy of Sciences 1173: 649–657.
|
| [36] | Rostami Nejad M, Rostami K, Cheraghipour K, Nazemalhosseini Mojarad E, Volta U, et al. (2011) Celiac disease increases the risk of Toxoplasma gondii infection in a large cohort of pregnant women. The American Journal of Gastroenterology 106: 548–549.
|
| [37] | Frank MM, Fries LF (1991) The role of complement in inflammation and phagocytosis. Immunology Today 12: 322–326.
|
| [38] | Barrington R, Zhang M, Fischer M, Carroll MC (2001) The role of complement in inflammation and adaptive immunity. Immunol Rev 180: 5–15.
|
| [39] | Walport MJ (2001) Complement. First of two parts. The New England Journal of Medicine 344: 1058–1066.
|
| [40] | Walport MJ (2001) Complement. Second of two parts. The New England Journal of Medicine 344: 1140–1144.
|
| [41] | Xiao J, Buka SL, Cannon TD, Suzuki Y, Viscidi RP, et al. (2009) Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect 11: 1011–1018.
|
| [42] | Severance EG, Gressitt K, Halling M, Stallings CR, Origoni AE, et al. (2012) Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiology of Disease 48: 447–53.
|
| [43] | Humphrey JH, Batty I (1976) Letter: International units and standards. Lancet 1: 800–801.
|
| [44] | Roberts CW, Cruickshank SM, Alexander J (1995) Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infection and immunity 63: 2549–2555.
|
| [45] | Liesenfeld O, Nguyen TA, Pharke C, Suzuki Y (2001) Importance of gender and sex hormones in regulation of susceptibility of the small intestine to peroral infection with Toxoplasma gondii tissue cysts. The Journal of Parasitology 87: 1491–1493.
|
| [46] | Drude S, Geissler A, Olfe J, Starke A, Domanska G, et al. (2011) Side effects of control treatment can conceal experimental data when studying stress responses to injection and psychological stress in mice. Lab Animal 40: 119–128.
|
| [47] | Silva IA, El Nabawi M, Hoover D, Silbergeld EK (2005) Prenatal HgCl2 exposure in BALB/c mice: gender-specific effects on the ontogeny of the immune system. Developmental and Comparative Immunology 29: 171–183.
|
| [48] | Wynne O, Horvat JC, Osei-Kumah A, Smith R, Hansbro PM, et al. (2011) Early life infection alters adult BALB/c hippocampal gene expression in a sex specific manner. Stress 14: 247–261.
|
| [49] | Lambert GP (2009) Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. Journal of Animal Science 87: E101–108.
|
| [50] | Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136: 2003–2014.
|
| [51] | Soderholm JD, Perdue MH (2001) Stress and gastrointestinal tract. II. Stress and intestinal barrier function. American Journal of Physiology Gastrointestinal and Liver Physiology 280: G7–G13.
|
| [52] | Munoz M, Liesenfeld O, Heimesaat MM (2011) Immunology of Toxoplasma gondii.. Immunological Reviews 240: 269–285.
|
| [53] | Liesenfeld O (1999) Immune responses to Toxoplasma gondii in the gut. Immunobiology 201: 229–239.
|
| [54] | Weight CM, Carding SR (2012) The protozoan pathogen Toxoplasma gondii targets the paracellular pathway to invade the intestinal epithelium. Annals of the New York Academy of Sciences 1258: 135–142.
|
| [55] | Liesenfeld O (2002) Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185 Suppl 1S96–101.
|
| [56] | Egan CE, Cohen SB, Denkers EY (2011) Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger. Immunology and Cell Biology 90: 668–75.
|
| [57] | Menard S, Lebreton C, Schumann M, Matysiak-Budnik T, Dugave C, et al. (2012) Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. The American Journal of Pathology 180: 608–615.
|
| [58] | Matysiak-Budnik T, Candalh C, Dugave C, Namane A, Cellier C, et al. (2003) Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 125: 696–707.
|
| [59] | Heyman M, Abed J, Lebreton C, Cerf-Bensussan N (2011) Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 61: 1355–64.
|
| [60] | Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, et al. (2011) Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Medicine 9: 23.
|
| [61] | Lammers KM, Lu R, Brownley J, Lu B, Gerard C, et al.. (2008) Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135: 194–204 e193.
|
| [62] | Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, et al. (2009) Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences of the United States of America 106: 16799–16804.
|
| [63] | Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, et al. (2006) Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian Journal of Gastroenterology 41: 408–419.
|
| [64] | Sander GR, Cummins AG, Henshall T, Powell BC (2005) Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Letters 579: 4851–4855.
|
| [65] | Rallabhandi P (2012) Gluten and celiac disease–an immunological perspective. Journal of AOAC International 95: 349–355.
|
| [66] | Karlsson H, Blomstrom A, Wicks S, Yang S, Yolken RH, et al. (2012) Maternal Antibodies to Dietary Antigens and Risk for Nonaffective Psychosis in Offspring. The American Journal of Psychiatry 169: 625–32.
|
| [67] | Boulanger LM (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64: 93–109.
|
| [68] | Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, et al. (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164–1178.
|
